buddlejasaponin iv has been researched along with Anasarca in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, JW; Im, HT; Kim, YH; Lee, KT; Park, HJ; Won, JH; Yun, KJ | 1 |
1 other study(ies) available for buddlejasaponin iv and Anasarca
Article | Year |
---|---|
Anti-inflammatory effect of buddlejasaponin IV through the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via the NF-kappaB inactivation.
Topics: Animals; Blotting, Western; Cell Line; Cyclooxygenase 2; Dose-Response Relationship, Drug; Edema; Electrophoretic Mobility Shift Assay; Gene Expression; Interleukin-1; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Molecular Structure; NF-kappa B; Nitric Oxide Synthase Type II; Phosphorylation; Protein Binding; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; Saponins; Triterpenes; Tumor Necrosis Factor-alpha | 2006 |